Magnetothermal nanoparticle technology alleviates parkinsonian symptoms in mice

Código QR

Magnetothermal nanoparticle technology alleviates parkinsonian symptoms in mice

Guardado en:

Detalles Bibliográficos
Autor principal:	Sarah Hescham
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/4f91449dfa744f7b87b66b617a6a4e4d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Magnetothermal nanoparticle technology alleviates parkinsonian-like symptoms in mice
por: Sarah-Anna Hescham, et al.
Publicado: (2021)

Wireless magnetomechanical and magnetothermal neuromodulation with magnetite nandiscs
por: Danijela Gregurec, et al.
Publicado: (2021)

Wireless deep brain stimulation in freely moving mice with nonresonant powering of magnetoelectric nanoparticles
por: Ali Jahanshahi, et al.
Publicado: (2021)

Connectome-targeted neuromodulation across symptoms and disorders
por: Shan Siddiqi
Publicado: (2021)

At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
por: Sarah Huffman, et al.
Publicado: (2021)

At-home telemedicine controlled taVNS twice daily for 4 weeks reduces long COVID symptoms of anxiety and fatigue
por: Christopher Austelle, et al.
Publicado: (2021)

Progression to vascular dementia of patients with mild cognitive impairment: relevance of mild parkinsonian signs
por: Marco Mauri, et al.
Publicado: (2008)

Structure and stability of symptoms in first episode psychosis: a longitudinal network approach
por: Siân Lowri Griffiths, et al.
Publicado: (2021)

EEG microstates changes in schizophrenia patients with negative symptoms after accelerated repetitive transcranial magnetic stimulation
por: Tomas Sverak, et al.
Publicado: (2021)

Baseline symptom profile does not predict early response to electroconvulsive therapy (ECT) in major depressive disorder (MDD)
por: Bijan Zarrabi, et al.
Publicado: (2021)

App-based ecological momentary assessment and symptom-adaptive scheduling of TMS maintenance treatments to prevent depressive episode recurrence
por: Linda Carpenter, et al.
Publicado: (2021)

Association Between Metabolic Syndrome and Mild Parkinsonian Signs Progression in the Elderly
por: Zeyan Peng, et al.
Publicado: (2021)

Chemo/optogenetic stimulation and photometry monitoring of neuron activity in mice
por: Yunlei Yang
Publicado: (2021)

A comparison of symptom-specific resting state functional connectivity biomarkers of 10 Hz and iTBS-rTMS in treatment-resistant depression
por: Katharine Dunlop, et al.
Publicado: (2021)

Corrigendum: Association Between Metabolic Syndrome and Mild Parkinsonian Signs Progression in the Elderly
por: Zeyan Peng, et al.
Publicado: (2021)

Hindbrain TMS in mice elicits structural and functional changes related to improvements in processing speed
por: M. Windy McNerney, et al.
Publicado: (2021)

Focal stimulation of movement related cortical potentials in mice using a novel TMS circuit design
por: Haley Strong, et al.
Publicado: (2021)

Correction to: APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline
por: Wenting Fang, et al.
Publicado: (2021)

Transauricular vagal nerve stimulation at 40Hz attenuates hippocampal amyloid load in 6-month-old APP/PS mice
por: Yutian Yu, et al.
Publicado: (2021)

Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761&reg;. Findings from a randomized controlled trial
por: Bachinskaya N, et al.
Publicado: (2011)

The “RF-EEG Cap”: a technological solution for high sensitivity whole-head concurrent TMS/EEG/fMRI experiments at 3T
por: Lucia Navarro de Lara, et al.
Publicado: (2021)

Dopaminergic Modulation of Spectral and Spatial Characteristics of Parkinsonian Subthalamic Nucleus Beta Bursts
por: Matthias Sure, et al.
Publicado: (2021)

Repetitive transcranial magnetic stimulation (rTMS) for catatonia– a case report
por: Christiane Licht, et al.
Publicado: (2021)

Integrating electrical field maps and alcohol cue-reactivity patterns to improve TMS treatment outcome in Alcohol Use Disorder: a retrospective analysis
por: Daniel McCalley, et al.
Publicado: (2021)

Increasing the number of daily stimulation sessions administered during taVNS-paired bottle feeding speeds response time in newborns with feeding difficulty
por: Lauren Adams, et al.
Publicado: (2021)

Does Synchronizing TMS pulses with EEG alpha Phase improve the Antidepressant Efficacy of Prefrontal TMS?
por: Sarah Huffman, et al.
Publicado: (2021)

Outcomes from University of Minnesota Clinical rTMS Clinic for resistant depression: naturalistic data on suicidal ideation
por: A.Irem Sonmez, et al.
Publicado: (2021)

Hippocampal potentials evoked by network-targeted stimulation vary by theta phase
por: Sarah M. Lurie, et al.
Publicado: (2021)

Covid effects on clinical outcomes of TMS treatment: a naturalistic study
por: A.IREM SONMEZ, et al.
Publicado: (2021)

Theta synchronized closed-loop stimulation increases hippocampal excitability in humans
por: James Kragel, et al.
Publicado: (2021)

Six weeks of daily prefrontal closed-loop repetitive transcranial magnetic stimulation (rTMS) produces progressive EEG-α phase entrainment in depressed adults
por: Josef Faller, et al.
Publicado: (2021)

Can passive measurement of physiological distress help better predict suicidal thinking?
por: Evan M. Kleiman, et al.
Publicado: (2021)

Widespread attenuating changes in brain connectivity associated with the general factor of psychopathology in 9- and 10-year olds
por: Chandra Sripada, et al.
Publicado: (2021)

Biofeedback as an intervention for persistent post-concussive symptoms: A randomized feasibility trial
por: Marquise M Bonn, et al.
Publicado: (2021)

Noradrenergic symptom cluster in depression
por: Montgomery S, et al.
Publicado: (2011)

Neuropsychiatric symptoms and celiac disease
por: Urban-Kowalczyk M, et al.
Publicado: (2014)

Behavioral symptoms related to cognitive impairment
por: Dillon C, et al.
Publicado: (2013)

Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients
por: Klaus Oliver Schubert, et al.
Publicado: (2021)

Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Ann M Mortimer
Publicado: (2009)

The noradrenergic symptom cluster: clinical expression and neuropharmacology
por: Blier P, et al.
Publicado: (2011)